|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BIOJECT MEDICAL TECHNOLOGIES INC, 10-Q, 2000-08-10 |
Next: SOUTHWEST ROYALTIES INSTITUTIONAL INCOME FUND VII-B L P, 10-Q, 2000-08-10 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 6,623,036
<SECURITIES> 0
<RECEIVABLES> 509,639
<ALLOWANCES> 20,871
<INVENTORY> 751,008
<CURRENT-ASSETS> 7,963,037
<PP&E> 4,654,987
<DEPRECIATION> 3,439,219
<TOTAL-ASSETS> 9,744,779
<CURRENT-LIABILITIES> 1,125,764
<BONDS> 0
0
14,985,464
<COMMON> 55,972,217
<OTHER-SE> (62,338,666)
<TOTAL-LIABILITY-AND-EQUITY> 9,744,779
<SALES> 345,539
<TOTAL-REVENUES> 493,512
<CGS> 576,644
<TOTAL-COSTS> 1,611,647
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (1,001,228)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,281,159)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,281,159)
<EPS-BASIC> (0.20)
<EPS-DILUTED> (0.20)
</TABLE>
|
|